Loading clinical trials...
Loading clinical trials...
CLINICAL PROTOCOL for the INVESTIGATION Of the BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007
The BioProtect Balloon Implant™ System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the balloon to reduce the radiation dose delivered to the anterior rectum. The balloon composed of a biodegradable material that maintains that space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.
This study will be a prospective, multi-center, randomized, double-arm, single blind, concurrently controlled study to assess the safety and efficacy of the balloon in prostate cancer subjects undergoing radiotherapy by means of intensity modulation radiation therapy (IMRT).
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Western Radiation Oncology
Apple Valley, California, United States
KSK Medical Center
Irvine, California, United States
Advanced Urology Institute
Daytona Beach, Florida, United States
Rush University Cancer Center
Chicago, Illinois, United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
Chesapeake Urology Research Associates
Owings Mills, Maryland, United States
Urology Nevada
Reno, Nevada, United States
Advanced Radiation Center of New York
Lake Success, New York, United States
New York University Langone Health
New York, New York, United States
Medical University of South Carolina (MUSC)
Charleston, South Carolina, United States
Start Date
January 3, 2018
Primary Completion Date
December 10, 2021
Completion Date
December 10, 2021
Last Updated
February 18, 2025
222
ACTUAL participants
balloon
DEVICE
Control
OTHER
Lead Sponsor
BioProtect
NCT04550494
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions